Understanding prognosis and survival outcomes in patients with early-stage non-small-cell lung cancer.
作者信息
Torrente Maria, Sousa Pedro A, Franco Fabio, Guerreiro Gracinda, Sousa Alexandre, Parejo Consuelo, Pimentao Joao, Provencio Mariano
机构信息
Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Spain.
Universidade Nova de Lisboa, Lisbon, Portugal.
出版信息
Clin Med (Lond). 2022 Jul;22(Suppl 4):38-40. doi: 10.7861/clinmed.22-4-s38.
Abstract
摘要
相似文献
1
Understanding prognosis and survival outcomes in patients with early-stage non-small-cell lung cancer.了解早期非小细胞肺癌患者的预后和生存结果。
Clin Med (Lond). 2022 Jul;22(Suppl 4):38-40. doi: 10.7861/clinmed.22-4-s38.
2
Optimal therapy for elderly patients with early stage non-small cell lung cancer.老年早期非小细胞肺癌患者的最佳治疗方法。
Am J Respir Crit Care Med. 2010 Feb 1;181(3):201-2. doi: 10.1164/rccm.200910-1558ED.
3
Natural history of stage I lung cancer.I期肺癌的自然史。
Chest. 2007 Dec;132(6):2062; author reply 2062-3. doi: 10.1378/chest.07-2032.
4
Arterial invasion predicts early mortality in stage I non-small cell lung cancer.血管侵犯可预测Ⅰ期非小细胞肺癌的早期死亡率。
Ann Thorac Surg. 2004 Nov;78(5):1748-53. doi: 10.1016/j.athoracsur.2004.04.061.
5
Bone metastasis after stage IIIA non-small cell lung cancer: risks and prognosis.IIIA期非小细胞肺癌后的骨转移：风险与预后
J Bras Pneumol. 2022 Nov 4;48(5):e20220211. doi: 10.36416/1806-3756/e20220211.
6
Comparison of seventh TNM and eighth TNM staging system in stage III non-small cell lung cancer patients treated with concurrent chemoradiotherapy.同步放化疗治疗的Ⅲ期非小细胞肺癌患者中第七版与第八版TNM分期系统的比较
Curr Probl Cancer. 2019 Feb;43(1):33-42. doi: 10.1016/j.currproblcancer.2018.04.002. Epub 2018 Apr 30.
7
Skip N2 Metastasis Shows Similar Prognosis to N1 Disease in Lung Cancer: Mechanism Discussion.跳跃式 N2 转移在肺癌中的预后与 N1 疾病相似：机制探讨
Clin Lung Cancer. 2021 Mar;22(2):e139-e140. doi: 10.1016/j.cllc.2020.10.004. Epub 2020 Oct 14.
8
[Is the current TNM classification still the best criterion for choosing treatment for non-small-cell lung cancer?].[当前的TNM分类仍然是选择非小细胞肺癌治疗方法的最佳标准吗？]
Rev Pneumol Clin. 2006 Jun;62(3):157-61. doi: 10.1016/s0761-8417(06)75431-1.
9
Prognostic factors of advanced stage non-small-cell lung cancer.晚期非小细胞肺癌的预后因素
Tunis Med. 2016 May;94(5):360-367.
10
Visceral pleura invasion by non-small cell lung cancer: an underrated bad prognostic factor.非小细胞肺癌侵犯脏层胸膜：一个被低估的不良预后因素。
Ann Thorac Surg. 2001 Apr;71(4):1088-93. doi: 10.1016/s0003-4975(00)02649-7.
本文引用的文献
1
Cancer statistics, 2022.癌症统计数据，2022 年。
CA Cancer J Clin. 2022 Jan;72(1):7-33. doi: 10.3322/caac.21708. Epub 2022 Jan 12.
2
Association of Survival With Adjuvant Chemotherapy Among Patients With Early-Stage Non-Small Cell Lung Cancer With vs Without High-Risk Clinicopathologic Features.早期非小细胞肺癌伴或不伴高危临床病理特征患者的辅助化疗与生存的关系。
JAMA Oncol. 2020 Nov 1;6(11):1741-1750. doi: 10.1001/jamaoncol.2020.4232.
3
Stratification of Patients With Stage IB NSCLC Based on the 8th Edition of the American Joint Committee on Cancer (AJCC) Staging Manual.根据美国癌症联合委员会（AJCC）第8版分期手册对IB期非小细胞肺癌患者进行分层。
Front Oncol. 2020 Apr 21;10:571. doi: 10.3389/fonc.2020.00571. eCollection 2020.
4
Recurrence after surgery in patients with NSCLC.非小细胞肺癌患者手术后的复发。
Transl Lung Cancer Res. 2014 Aug;3(4):242-9. doi: 10.3978/j.issn.2218-6751.2013.12.05.
5
Adjuvant chemotherapy for resected early-stage non-small cell lung cancer.早期非小细胞肺癌切除术后的辅助化疗
Cochrane Database Syst Rev. 2015 Mar 2;2015(3):CD011430. doi: 10.1002/14651858.CD011430.
6
Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.早期及局部晚期（非转移性）非小细胞肺癌：ESMO临床诊断、治疗及随访实践指南
Ann Oncol. 2010 May;21 Suppl 5:v103-15. doi: 10.1093/annonc/mdq207.
7
Long-term results of the international adjuvant lung cancer trial evaluating adjuvant Cisplatin-based chemotherapy in resected lung cancer.国际辅助肺癌试验的长期结果，评估了辅助顺铂为基础的化疗在可切除肺癌中的应用。
J Clin Oncol. 2010 Jan 1;28(1):35-42. doi: 10.1200/JCO.2009.23.2272. Epub 2009 Nov 23.
Zotero 插件